Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_assertion type Assertion NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_head.
- NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_assertion description "[The severely affected DMD patients have little or no detectable dystrophin in their muscle, whereas BMD patients have nearly normal concentrations of an altered form of dystrophin; patients with all other neuromuscular diseases have normal dystrophin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_provenance.
- NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_assertion evidence source_evidence_literature NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_provenance.
- NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_assertion SIO_000772 2663232 NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_provenance.
- NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_assertion wasDerivedFrom befree-20140225 NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_provenance.
- NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_assertion wasGeneratedBy ECO_0000203 NP516871.RAzfq7WbZ_GY3zpuj4fsvYv8tdzb6M8K1-wM1zExK5uhM130_provenance.